These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32356908)

  • 1. Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.
    Du SQ; Yuan W
    J Med Virol; 2020 Sep; 92(9):1615-1628. PubMed ID: 32356908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments.
    Sadria M; Layton AT
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34198530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
    Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
    Ruenjaiman V; Hirankarn N; Palaga T
    Asian Pac J Allergy Immunol; 2021 Jun; 39(2):69-77. PubMed ID: 34174806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.
    Caron J; Ridgley LA; Bodman-Smith M
    Front Immunol; 2021; 12():666983. PubMed ID: 33854516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities.
    Galani IE; Andreakos E
    Semin Immunol; 2021 Jun; 55():101522. PubMed ID: 34815163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis guided therapeutic management of COVID-19: an immunological perspective.
    Kumar A; Prasoon P; Sekhawat PS; Pareek V; Faiq MA; Kumari C; Narayan RK; Kulandhasamy M; Kant K
    Int Rev Immunol; 2021; 40(1-2):54-71. PubMed ID: 33111578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques.
    Mochan E; Sego TJ; Gaona L; Rial E; Ermentrout GB
    Bull Math Biol; 2021 May; 83(7):79. PubMed ID: 34037874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune responses against coronavirus.
    Hosseini A; Hashemi V; Shomali N; Asghari F; Gharibi T; Akbari M; Gholizadeh S; Jafari A
    Biomed Pharmacother; 2020 Dec; 132():110859. PubMed ID: 33120236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.
    Darbeheshti F; Mahdiannasser M; Uhal BD; Ogino S; Gupta S; Rezaei N
    Rev Med Virol; 2021 Nov; 31(6):e2234. PubMed ID: 33724604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
    Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
    Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and the immune system.
    Paces J; Strizova Z; Smrz D; Cerny J
    Physiol Res; 2020 Jul; 69(3):379-388. PubMed ID: 32469225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease.
    Todorović-Raković N; Whitfield JR
    Cytokine; 2021 Oct; 146():155637. PubMed ID: 34242899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.
    Tandel D; Sah V; Singh NK; Potharaju PS; Gupta D; Shrivastava S; Sowpati DT; Harshan KH
    Microbiol Spectr; 2022 Oct; 10(5):e0160422. PubMed ID: 36073824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling within-host dynamics of influenza virus infection including immune responses.
    Pawelek KA; Huynh GT; Quinlivan M; Cullinane A; Rong L; Perelson AS
    PLoS Comput Biol; 2012; 8(6):e1002588. PubMed ID: 22761567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and delicate balance of Host Immunity in Coronavirus Disease-19.
    Vyas AK; Varma V; Garg G; Gupta P; Trehanpati N
    Iran J Immunol; 2021 Mar; 18(1):1-12. PubMed ID: 33787510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.